Rhythm Pharmaceuticals (RYTM) Prices 7.05M Share IPO at $17/Sh

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) today announced the pricing of its initial public offering of 7,050,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts. All of the shares are being offered by Rhythm. In addition, Rhythm has granted the underwriters a 30-day option to purchase up to an additional 1,057,500 shares of common stock at the initial public offering price. The shares are scheduled to begin trading on the NASDAQ Global Market under the ticker symbol "RYTM" on Thursday, October 5, 2017. The offering is expected to close on October 10, 2017, subject to the satisfaction of customary closing conditions.

Morgan Stanley, BofA Merrill Lynch and Cowen are acting as the lead book-running managers of the offering. Needham & Company is acting as the co-manager for the proposed offering.

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Sky Harbour adds $10M via share sale to M-Cor Capital
• EShallGo closes $1.75M registered direct offering at $1 per share